Sound Bioventures
Swedensoundbioventures.com
Overview
Sound Bioventures is a venture capital fund investing in about-to-be clinical and clinical stage private companies in Europe and the USA developing novel medicines that addresses unmet medical needs. The fund focuses on companies with assets in clinical or about-to-be-clinical stage in primarily orphan and rare diseases. It leverages Scandinavian science to build companies and facilitate cross-Atlantic exchange of innovation, sector knowledge and capital.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| AnaCardio | Sep 2026 | Series B | Co-investor |
| Breye Therapeutics | Sep 2026 | Series A | Co-investor |
| Cytospire Therapeutics | May 2026 | Series A | Co-investor |
| BOOST Pharma | Nov 2025 | Convertible Debt | Lead |
| ARTHEx Biotech | Sep 2025 | Series B | Co-investor |
Key People
Ester Sklarsky
Principal
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
See something wrong or outdated?